Calvert, A H <br/><br/>
A phase I evaluation of the quinazoline antifolate thymidylate synthase inhibitor, N10-propargyl-5,8-dideazafolic acid, CB3717.  [electronic resource] 

 -  Journal of clinical oncology : official journal of the American Society of Clinical Oncology  Aug 1986 
 - 1245-52 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>0732-183X 
<br/><br/><label>Standard No.: </label>10.1200/JCO.1986.4.8.1245  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Acetylglucosaminidase--urine<br/>Acid Phosphatase--blood<br/>Alanine Transaminase--blood<br/>Antineoplastic Agents--administration & dosage<br/>Chemical and Drug Induced Liver Injury<br/>Dose-Response Relationship, Drug<br/>Drug Administration Schedule<br/>Drug Evaluation<br/>Folic Acid--analogs & derivatives<br/>Folic Acid Antagonists--administration & dosage<br/>Glomerular Filtration Rate--drug effects<br/>Hematologic Diseases--chemically induced<br/>Hyperbilirubinemia--chemically induced<br/>Kidney Diseases--chemically induced<br/>Leucyl Aminopeptidase--urine<br/>Neoplasms--blood<br/>Quinazolines--administration & dosage<br/>Skin Diseases--chemically induced<br/>Thymidylate Synthase--antagonists & inhibitors